(19)
(11) EP 2 968 295 A1

(12)

(43) Date of publication:
20.01.2016 Bulletin 2016/03

(21) Application number: 14768961.6

(22) Date of filing: 10.03.2014
(51) International Patent Classification (IPC): 
A61K 31/4427(2006.01)
A61K 31/444(2006.01)
A61K 31/4439(2006.01)
A61P 7/00(2006.01)
(86) International application number:
PCT/US2014/022733
(87) International publication number:
WO 2014/150256 (25.09.2014 Gazette 2014/39)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 15.03.2013 US 201313815872
31.07.2013 US 201361860793 P

(71) Applicant: Global Blood Therapeutics, Inc.
South San Francisco, CA 94080 (US)

(72) Inventors:
  • SINHA, Uma
    South San Francisco, CA 94080 (US)
  • METCALF, Brian, W.
    South San Francisco, CA 94080 (US)
  • OKSENBERG, Donna
    South San Francisco, CA 94080 (US)
  • DUFU, Kobina, N.
    South San Francisco, CA 94080 (US)
  • PATEL, Mira, P.
    South San Francisco, CA 94080 (US)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)

   


(54) COMPOSITIONS AND METHODS FOR THE MODULATION OF HEMOGLOBIN (S)